TCL Archive Organ Systems Program Finally Loses a Couple, But Gets OK for Breast Cancer Risk Study RFA June 20, 1986
TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004